Literature DB >> 23658380

Mild cognitive impairment: incidence and vascular risk factors in a population-based cohort.

Mary Ganguli1, Bo Fu, Beth E Snitz, Tiffany F Hughes, Chung-Chou H Chang.   

Abstract

OBJECTIVE: We examined the incidence of mild cognitive impairment (MCI) and its potential vascular risk factors in a prospective population-based study.
METHODS: An age-stratified random population-based cohort (baseline n = 1,982), followed for up to 4 years, was annually assessed for cognitive and everyday functioning. Incidence rates were calculated for both cognitive (neuropsychological [NP]-MCI) and functional (Clinical Dementia Rating [CDR] = 0.5) definitions of MCI. Several measures of vascular, metabolic, and inflammatory risk were assessed at baseline. Risk factor analyses used interval censoring survival models, followed by joint modeling of both MCI and attrition due to mortality and illness.
RESULTS: Incidence rates for NP-MCI and CDR = 0.5 were 95 and 55 per 1,000 person-years. In individual joint models, risk factors for NP-MCI were diabetes and adiposity (waist: hip ratio), while APOE ε4 genotype and heart failure increased risk of attrition. Adiposity, stroke, heart failure, and diabetes were risk factors for nonamnestic MCI. For CDR = 0.5, risk factors were stroke and heart failure; heart failure and adiposity increased risk of attrition. In multivariable joint models combining all risk factors, adiposity increased risk of NP-MCI, while stroke and heart failure increased risk for CDR = 0.5. Current alcohol use appeared protective against all subtypes.
CONCLUSION: Incidence of MCI increased with age regardless of definition and did not vary by sex or education. Several vascular risk factors elevated the risk of incident MCI, whether defined cognitively or functionally, but most were associated with nonamnestic MCI and CDR = 0.5. Controlling vascular risk may potentially reduce risk of MCI.

Entities:  

Mesh:

Year:  2013        PMID: 23658380      PMCID: PMC3716350          DOI: 10.1212/WNL.0b013e318295d776

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  38 in total

Review 1.  Mild cognitive impairment: disparity of incidence and prevalence estimates.

Authors:  Alex Ward; H Michael Arrighi; Shannon Michels; Jesse M Cedarbaum
Journal:  Alzheimers Dement       Date:  2012-01       Impact factor: 21.566

2.  The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging.

Authors:  R O Roberts; Y E Geda; D S Knopman; R H Cha; V S Pankratz; B F Boeve; E G Tangalos; R J Ivnik; W A Rocca; R C Petersen
Journal:  Neurology       Date:  2012-01-25       Impact factor: 9.910

3.  Outcomes of mild cognitive impairment by definition: a population study.

Authors:  Mary Ganguli; Beth E Snitz; Judith A Saxton; Chung-Chou H Chang; Ching-Wen Lee; Joni Vander Bilt; Tiffany F Hughes; David A Loewenstein; Frederick W Unverzagt; Ronald C Petersen
Journal:  Arch Neurol       Date:  2011-06

4.  Alzheimer's research. Stopping Alzheimer's before it starts.

Authors:  Greg Miller
Journal:  Science       Date:  2012-08-17       Impact factor: 47.728

Review 5.  Dementia, stroke, and vascular risk factors; a review.

Authors:  Ramesh Sahathevan; Amy Brodtmann; Geoffrey A Donnan
Journal:  Int J Stroke       Date:  2012-01       Impact factor: 5.266

6.  Central obesity in the elderly is related to late-onset Alzheimer disease.

Authors:  José A Luchsinger; Derek Cheng; Ming Xin Tang; Nicole Schupf; Richard Mayeux
Journal:  Alzheimer Dis Assoc Disord       Date:  2012 Apr-Jun       Impact factor: 2.703

7.  Smoking, death, and Alzheimer disease: a case of competing risks.

Authors:  Chung-Chou H Chang; Yongyun Zhao; Ching-Wen Lee; Mary Ganguli
Journal:  Alzheimer Dis Assoc Disord       Date:  2012 Oct-Dec       Impact factor: 2.703

8.  Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study-Cognition Study.

Authors:  Oscar L Lopez; James T Becker; Yue-Fang Chang; Robert A Sweet; Steven T DeKosky; Michael H Gach; Owen T Carmichael; Eric McDade; Lewis H Kuller
Journal:  Neurology       Date:  2012-09-26       Impact factor: 9.910

9.  Prevalence of mild cognitive impairment by multiple classifications: The Monongahela-Youghiogheny Healthy Aging Team (MYHAT) project.

Authors:  Mary Ganguli; Chung-Chou H Chang; Beth E Snitz; Judith A Saxton; Joni Vanderbilt; Ching-Wen Lee
Journal:  Am J Geriatr Psychiatry       Date:  2010-08       Impact factor: 4.105

10.  Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82 864 participants from nine cohort studies.

Authors:  S Czernichow; A-P Kengne; E Stamatakis; M Hamer; G D Batty
Journal:  Obes Rev       Date:  2011-04-27       Impact factor: 9.213

View more
  58 in total

1.  Brain health: the importance of recognizing cognitive impairment: an IAGG consensus conference.

Authors:  John E Morley; John C Morris; Marla Berg-Weger; Soo Borson; Brian D Carpenter; Natalia Del Campo; Bruno Dubois; Keith Fargo; L Jaime Fitten; Joseph H Flaherty; Mary Ganguli; George T Grossberg; Theodore K Malmstrom; Ronald D Petersen; Carroll Rodriguez; Andrew J Saykin; Philip Scheltens; Eric G Tangalos; Joe Verghese; Gordon Wilcock; Bengt Winblad; Jean Woo; Bruno Vellas
Journal:  J Am Med Dir Assoc       Date:  2015-09-01       Impact factor: 4.669

2.  Multimorbidity and Risk of Mild Cognitive Impairment.

Authors:  Maria Vassilaki; Jeremiah A Aakre; Ruth H Cha; Walter K Kremers; Jennifer L St Sauver; Michelle M Mielke; Yonas E Geda; Mary M Machulda; David S Knopman; Ronald C Petersen; Rosebud O Roberts
Journal:  J Am Geriatr Soc       Date:  2015-08-27       Impact factor: 5.562

3.  The Association of Late-Life Diabetes Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia: The ARIC Study.

Authors:  Andreea M Rawlings; A Richey Sharrett; Marilyn S Albert; Josef Coresh; B Gwen Windham; Melinda C Power; David S Knopman; Keenan Walker; Sheila Burgard; Thomas H Mosley; Rebecca F Gottesman; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2019-05-21       Impact factor: 19.112

4.  Vascular risk factors and cognitive decline in a population sample.

Authors:  Mary Ganguli; Bo Fu; Beth E Snitz; Frederick W Unverzagt; David A Loewenstein; Tiffany F Hughes; Chung-Chou H Chang
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jan-Mar       Impact factor: 2.703

5.  Cohort effects in age-associated cognitive trajectories.

Authors:  Hiroko H Dodge; Jian Zhu; Ching-Wen Lee; Chung-Chou Ho Chang; Mary Ganguli
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-11-23       Impact factor: 6.053

6.  Multimorbidity and neuroimaging biomarkers among cognitively normal persons.

Authors:  Maria Vassilaki; Jeremiah A Aakre; Michelle M Mielke; Yonas E Geda; Walter K Kremers; Rabe E Alhurani; Mary M Machulda; David S Knopman; Ronald C Petersen; Val J Lowe; Clifford R Jack; Rosebud O Roberts
Journal:  Neurology       Date:  2016-04-13       Impact factor: 9.910

7.  Rates and risk factors for progression to incident dementia vary by age in a population cohort.

Authors:  Mary Ganguli; Ching-Wen Lee; Beth E Snitz; Tiffany F Hughes; Eric McDade; Chung-Chou H Chang
Journal:  Neurology       Date:  2014-12-03       Impact factor: 9.910

Review 8.  A major role for cardiovascular burden in age-related cognitive decline.

Authors:  Chengxuan Qiu; Laura Fratiglioni
Journal:  Nat Rev Cardiol       Date:  2015-01-13       Impact factor: 32.419

9.  How well do MCI criteria predict progression to severe cognitive impairment and dementia?

Authors:  Mary Ganguli; Ching-Wen Lee; Beth E Snitz; Tiffany F Hughes; Eric M McDade; Chung-Chou H Chang
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Apr-Jun       Impact factor: 2.703

10.  The role of the Montreal Cognitive Assessment (MoCA) and its memory tasks for detecting mild cognitive impairment.

Authors:  Xudong Li; Shuhong Jia; Zhi Zhou; Yi Jin; Xiangfei Zhang; Chunlei Hou; Wenjing Zheng; Pei Rong; Jinsong Jiao
Journal:  Neurol Sci       Date:  2018-03-17       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.